Decreasing Delirium Through Music in Critically Ill Older Adults
DDM
2 other identifiers
interventional
160
1 country
5
Brief Summary
Critically ill older adults admitted to the intensive care unit (ICU) are at a higher risk to develop delirium, which predisposes them to longer lengths of ICU and hospital stay, increased in-patient mortality, and higher risk of new acquired cognitive impairment and dementia. Music listening is a non-pharmacological intervention that holds potential to decrease ICU delirium. The investigators propose a randomized controlled trial to evaluate the efficacy of a seven-day slow-tempo music intervention on the primary outcome of delirium/coma free days among mechanically ventilated, critically ill older adults.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2020
Longer than P75 for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 25, 2019
CompletedFirst Posted
Study publicly available on registry
December 2, 2019
CompletedStudy Start
First participant enrolled
March 5, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 8, 2024
CompletedResults Posted
Study results publicly available
January 3, 2025
CompletedSeptember 22, 2025
September 1, 2025
3.8 years
November 25, 2019
December 11, 2024
September 19, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Days Free of Delirium and Coma
Days free of delirium and coma will be the primary outcome for the trial. Days free of delirium and coma are the number of days after randomization patient is alive free of delirium and not in coma during the seven-day study intervention phase.
Seven day study intervention phase
Secondary Outcomes (9)
Delirium Severity
Subjects will be followed up to 28 days post randomization. The first 7 days were used for analysis per the protocol statistical plan.
Pain Intensity
4 times daily, before and after each intervention for up to 7 days while in the ICU and then twice daily up to 28 days post randomization. The first 7 days were used for analysis per the protocol statistical plan.
Anxiety
4 times daily, before and after each intervention for up to 7 days while in the ICU and then twice daily up to 28 days post randomization. The first 7 days were used for analysis per the protocol statistical plan.
Cognition
3 months post hospital discharge
Cognition
3 months post hospital discharge
- +4 more secondary outcomes
Study Arms (2)
Slow Tempo Music
EXPERIMENTALSlow-tempo 60-80 beats per minute relaxing music. The intervention includes two one-hour music listening sessions, once in the morning and once in the evening for up to seven days, delivered through noise-canceling headphones and iPad.
Attention Control
SHAM COMPARATOROne-hour sessions consisting of a silence track twice daily delivered through noise-cancelling headphones for up to 7 days.
Interventions
For up to seven days, enrolled subjects will receive one-hour slow tempo music listening sessions twice daily through noise-cancelling headphones.
Subjects will receive a noise cancellation headphone-applied condition identical to the music intervention experimental treatment in twice daily one hour-sessions for up to seven days.
Eligibility Criteria
You may qualify if:
- Age 50 years or older.
- English speaking.
- Admitted to the intensive care unit (medical or surgical).
- Expected mechanical ventilator support for ≥48 hours.
- Consentable through a legally authorized representative.
- Have access to a telephone.
You may not qualify if:
- History of dementing illnesses and other neurodegenerative diseases such as Alzheimer's disease or vascular dementia.
- Psychiatric illness which is not well controlled.
- Alcohol withdrawal symptoms/concern for withdrawal.
- Suspected or confirmed drug intoxication/overdose
- Traumatic brain injury, ischemic or hemorrhagic cerebrovascular accident, or undergoing neurosurgery.
- Uncorrected hearing or vision impairment including legal blindness.
- Incarcerated at the time of study enrollment.
- Enrolled in another clinical trial which does not permit co-enrollment.
- Any medical condition precluding safe use of headphones such as: skin breakdown, burns, facial or skull fractures.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Indiana Universitylead
- National Institute on Aging (NIA)collaborator
Study Sites (5)
IU Health West Hospital
Avon, Indiana, 46123, United States
Eskenazi Hospital
Indianapolis, Indiana, 46202, United States
IU Health University Hospital
Indianapolis, Indiana, 46202, United States
Methodist Hospital
Indianapolis, Indiana, 46202, United States
Mayo Clinic Rochester
Rochester, Minnesota, 55905, United States
Related Publications (2)
Khan BA, Khan SH, Perkins AJ, Heiderscheit A, Unverzagt FW, Wang S, Downs JH 3rd, Gao S, Chlan LL. Slow-Tempo Music and Delirium/Coma-Free Days Among Older Adults Undergoing Mechanical Ventilation: A Randomized Clinical Trial. JAMA Intern Med. 2025 Dec 1;185(12):1442-1453. doi: 10.1001/jamainternmed.2025.5263.
PMID: 41082215DERIVEDSeyffert S, Moiz S, Coghlan M, Balozian P, Nasser J, Rached EA, Jamil Y, Naqvi K, Rawlings L, Perkins AJ, Gao S, Hunter JD 3rd, Khan S, Heiderscheit A, Chlan LL, Khan B. Decreasing delirium through music listening (DDM) in critically ill, mechanically ventilated older adults in the intensive care unit: a two-arm, parallel-group, randomized clinical trial. Trials. 2022 Jul 19;23(1):576. doi: 10.1186/s13063-022-06448-w.
PMID: 35854358DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Babar Khan, MD, MS
- Organization
- Indiana University
Study Officials
- PRINCIPAL INVESTIGATOR
Babar Khan, MD, MS
Indiana University
- PRINCIPAL INVESTIGATOR
Linda Chlan, PhD, RN
Mayo Clinic
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Only the unblinded study coordinator is aware of randomization. Outcomes assessors are blinded
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Medicine
Study Record Dates
First Submitted
November 25, 2019
First Posted
December 2, 2019
Study Start
March 5, 2020
Primary Completion
December 15, 2023
Study Completion
April 8, 2024
Last Updated
September 22, 2025
Results First Posted
January 3, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share